- Clinical Trials
- April 2025
- 60 Pages
Global
From €1335EUR$1,500USD£1,155GBP
- Report
- May 2025
- 184 Pages
Global
From €3155EUR$3,545USD£2,731GBP
€3506EUR$3,939USD£3,034GBP
- Report
- May 2025
- 195 Pages
Global
From €3155EUR$3,545USD£2,731GBP
€3506EUR$3,939USD£3,034GBP
- Report
- May 2025
- 191 Pages
Global
From €3155EUR$3,545USD£2,731GBP
€3506EUR$3,939USD£3,034GBP
- Report
- May 2025
- 184 Pages
Global
From €3155EUR$3,545USD£2,731GBP
€3506EUR$3,939USD£3,034GBP
- Report
- May 2025
- 197 Pages
Global
From €3155EUR$3,545USD£2,731GBP
€3506EUR$3,939USD£3,034GBP
- Report
- April 2025
- 200 Pages
Global
From €2216EUR$2,490USD£1,918GBP
- Report
- June 2025
Global
From €4361EUR$4,900USD£3,774GBP
- Report
- April 2025
- 200 Pages
Global
From €3996EUR$4,490USD£3,459GBP
- Report
- February 2025
- 200 Pages
Global
From €3996EUR$4,490USD£3,459GBP
- Report
- February 2025
- 200 Pages
Global
From €3996EUR$4,490USD£3,459GBP
- Report
- February 2025
- 200 Pages
Global
From €3996EUR$4,490USD£3,459GBP
- Report
- July 2025
- 175 Pages
Global
From €3996EUR$4,490USD£3,459GBP
- Report
- April 2025
- 250 Pages
Global
From €3996EUR$4,490USD£3,459GBP
- Report
- April 2025
- 200 Pages
Global
From €3996EUR$4,490USD£3,459GBP
- Report
- April 2025
- 200 Pages
Global
From €3996EUR$4,490USD£3,459GBP
- Report
- March 2025
- 175 Pages
Global
From €3996EUR$4,490USD£3,459GBP
- Report
- February 2025
- 200 Pages
Global
From €3996EUR$4,490USD£3,459GBP
- Report
- November 2024
- 150 Pages
Global
From €2893EUR$3,250USD£2,503GBP
€4317EUR$4,850USD£3,736GBP
- Report
- July 2025
- 274 Pages
Global
From €5207EUR$5,850USD£4,506GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more